Skip to content

Clinical trials

Observational Spondylitis, Ankylosing trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Spondylitis, Ankylosing Phase: Observational Clear all

216 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20034
20046
20052
20065
20078
20086
20098
20107
20119
201213
20138
20146
201511
20167
20174
201812
20197
202012
202111
202213
202316
202411
202512
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed121
Recruiting32
Unknown status28
Not yet recruiting14
Active, not recruiting8
Terminated8
Withdrawn3
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie11
Pfizer11
AbbVie (prior sponsor, Abbott)9
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)7
Assiut University6
Istanbul Physical Medicine Rehabilitation Training and Research Hospital6
AstraZeneca4
Merck Sharp & Dohme LLC4
Novartis Pharmaceuticals4
University Hospital, Grenoble4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Spondylitis, Ankylosing216
Arthritis, Rheumatoid88
Arthritis, Psoriatic72
Crohn Disease30
Psoriasis26
Colitis, Ulcerative23
Spondylarthritis22
Axial Spondyloarthritis16
Arthritis15
Lupus Erythematosus, Systemic15

Trials

Showing 26 to 50 of 216. Each trial links to its page on Pharma Observatory.

116 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.